ipilimumab,nivolumab
bms
['sclc', 'lcsm,(-blcsm)', 'check,mate,227', '/ipi', 'nivo', 'nsclc']
dr presents a poster at #asco22 showing the continued success of checkmate227 comparing nivo/ipi vs chemo. after 5 years, responses were maintained for &gt;5 yrs in &gt;40% of responders. #lcsm #nsclc 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.